Last reviewed · How we verify

NCT06286605

RCT GBR One Stages Comparing A-Oss and Autogenous Bone Versus A-Oss and LCR-A

Not yet recruiting NA Last updated 29 February 2024
What this trial tests

NA trial testing A-oss and autogenous bone in Guided Bone Regeneration in 42 participants. Not yet recruiting.

Timeline
1 March 2024
Primary endpoint
30 December 2024
30 December 2028

Quick facts

Lead sponsorUniversità degli Studi di Sassari
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment42
Start date1 March 2024
Primary completion30 December 2024
Estimated completion30 December 2028
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Università degli Studi di Sassari

Who can join

18 and older, any sex, with Guided Bone Regeneration or Dental Implant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this randomized controlled trial is to evaluate the tridimensional bone stability after horizontal one-stage GBR using collagene membrane (OssMem) with a mix of Bovine Bone Substitute (A-Oss) and autogenous bone (test group) versus A-Oss and LCR-A, a synthetic bone (control group).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Guided Bone Regeneration

Currently open trials in the same condition.

Other Università degli Studi di Sassari trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06286605.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing